Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.46 |
| ▸ | MMP9 | P14780 | 2/20 | 0.46 |
| ▸ | MMP8 | P22894 | 2/20 | 0.46 |
| ▸ | MMP14 | P50281 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.41 |
| ▸ | PYGL | P06737 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SLC12A2 | P55011 | 1/20 | 0.40 |
| ▸ | SLC12A5 | Q9H2X9 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7207304 | 1.00 | KMT2A (0.53) | KMT2ACAPN1MMP9MMP8MMP14 | |
| SCHEMBL29706360 | 1.00 | KMT2A (0.53) | KMT2ACAPN1MMP9MMP8MMP14 | |
| SCHEMBL7207300 | 1.00 | KMT2A (0.53) | KMT2ACAPN1MMP9MMP8MMP14 | |
| SCHEMBL8205498 | 0.90 | MMP9 (0.43) | KMT2ACAPN1MMP9MMP8MMP14 | |
| SCHEMBL7211686 | 0.90 | MMP9 (0.43) | KMT2ACAPN1MMP9MMP8MMP14 | |
| SCHEMBL7203966 | 0.88 | MMP9 (0.53) | KMT2AMMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL7203960 | 0.88 | MMP9 (0.53) | KMT2AMMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL7204429 | 0.87 | KMT2A (0.59) | KMT2ACAPN1MMP8ALDH1A1TSHR | |
| SCHEMBL7204422 | 0.87 | KMT2A (0.59) | KMT2ACAPN1MMP8ALDH1A1TSHR | |
| SCHEMBL7211698 | 0.87 | MMP9 (0.43) | KMT2ACAPN1MMP9MMP8MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070123483-A1 | Method and composition for treating obesity by targeting cathespin | NMPI, LLC | 2007-05-31 | — | — | US | disclosed |
| US-20070123483-A1 | Method and composition for treating obesity by targeting cathespin | NMPI, LLC | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070123483-A1 | Method and composition for treating obesity by targeting cathespin | CTSS, PRKCSH, CTSG | KMT2A 2926/4885CAPN1 79/4885MMP9 831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.